Market Overview
According to DIResearch's in-depth investigation and research, the global Bacteriophage market size will reach 66.67 Million USD in 2025 and is projected to reach 224.24 Million USD by 2032, with a CAGR of 18.92% (2025-2032). Notably, the China Bacteriophage market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Bacteriophage, also known as phage, is a type of virus that infects and replicates within bacteria. It is a microscopic entity that is composed of genetic material (either DNA or RNA) and a protein capsid. Bacteriophages attach to specific receptors on the surface of bacterial cells, inject their genetic material into the host, and use the host's machinery to reproduce and release new phages. They are found in all environments where bacteria are present and are being studied extensively for their potential use in treating bacterial infections.
The major global suppliers of Bacteriophage include BiomX (Adaptive Phage Therapeutics), Armata Pharmaceuticals, Cytophage Technologies, Phaxiam, Locus, Biosciences, Inc, TechnoPhage, NPO Microgen, Qingdao Noan Baite Biotechnology Co., Ltd, MicroMir, Biochimpharm, Proteon Pharmaceuticals, iNtRON Biotechnology, PrecisioBiotix, Eliava BioPreparations, Shandong New Route Biotechnology Co., Ltd, Intralytix, Micreos (Phageguard), Xiamen CANCO Biological Engineering Co., Ltd, Qingdao Run Da Biotechnology Co., Ltd, NexaBiome, Shandong Zhongchuang Health Technology Group, CreatiPhage, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Bacteriophage. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Bacteriophage market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Bacteriophage market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Bacteriophage industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Bacteriophage Include:
BiomX (Adaptive Phage Therapeutics)
Armata Pharmaceuticals
Cytophage Technologies
Phaxiam
Locus
Biosciences, Inc
TechnoPhage
NPO Microgen
Qingdao Noan Baite Biotechnology Co., Ltd
MicroMir
Biochimpharm
Proteon Pharmaceuticals
iNtRON Biotechnology
PrecisioBiotix
Eliava BioPreparations
Shandong New Route Biotechnology Co., Ltd
Intralytix
Micreos (Phageguard)
Xiamen CANCO Biological Engineering Co., Ltd
Qingdao Run Da Biotechnology Co., Ltd
NexaBiome
Shandong Zhongchuang Health Technology Group
CreatiPhage
Bacteriophage Product Segment Include:
Natural Phages
Synthetic Phages
Bacteriophage Product Application Include:
Human Health
Animal Health
Agricultural Planting
Food Safety
Environmental Disinfection
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Bacteriophage Industry PESTEL Analysis
Chapter 3: Global Bacteriophage Industry Porter's Five Forces Analysis
Chapter 4: Global Bacteriophage Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Bacteriophage Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Bacteriophage Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Bacteriophage Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook